Literature DB >> 11896411

Molecular aspects of hepatic carcinogenesis.

Marcelo Eidi Nita1, Venâncio Avancini Ferreira Alves, Flair José Carrilho, Suzane Kioko Ono-Nita, Evandro Sobroza de Mello, Joaquim J Gama-Rodrigues.   

Abstract

Exogenous agents correlated with hepatocellular carcinoma (HCC) have been identified and well characterized. These agents, including the different viruses that cause chronic hepatitis and cirrhosis, can lead to regenerative nodules and dysplastic nodules/adenomatous hyperplasia. These conditions associated with several molecular alterations of hepatocyte ultimately culminate in hepatocellular carcinoma. Recently, there has been a great progress in the identification of somatic and germinative mutations that may be correlated with the development of HCC, justifying a review on the subject. Hence, the factors involved in the process of hepatic carcinogenesis, such as infection by the hepatitis B and C viruses, with a special focus in the molecular alterations described in recent years are discussed herein, pointing out areas potentially relevant for clinical development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11896411     DOI: 10.1590/s0036-46652002000100007

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  3 in total

1.  Antisense oligonucleotide targeting at the initiator of hTERT arrests growth of hepatoma cells.

Authors:  Su-Xia Liu; Wen-Sheng Sun; Ying-Lin Cao; Chun-Hong Ma; Li-Hui Han; Li-Ning Zhang; Zhen-Guang Wang; Fa-Liang Zhu
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

2.  Mutations in TP53 and CTNNB1 in Relation to Hepatitis B and C Infections in Hepatocellular Carcinomas from Thailand.

Authors:  Olivier Galy; Isabelle Chemin; Emilie Le Roux; Stéphanie Villar; Florence Le Calvez-Kelm; Myriam Lereau; Doriane Gouas; Beatriz Vieco; Iris Suarez; Maria-Cristina Navas; Michèle Chevallier; Helene Norder; Petcharin Srivatanakul; Anant Karalak; Suleeporn Sangrajrang; Christian Trépo; Pierre Hainaut
Journal:  Hepat Res Treat       Date:  2011-06-30

3.  249 TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients.

Authors:  Jeronimo A Nogueira; Suzane K Ono-Nita; Marcelo E Nita; Marcelo M T de Souza; Eliane P do Carmo; Evandro S Mello; Cristovan Scapulatempo; Denise C Paranaguá-Vezozzo; Flair J Carrilho; Venancio A F Alves
Journal:  BMC Cancer       Date:  2009-06-26       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.